The risk or severity of adverse effects can be increased when ethchlorvynol is combined with maprotiline.


The risk or severity of adverse effects can be increased when betaxolol is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when baclofen is combined with doxepin.


The risk or severity of adverse effects can be increased when carbamazepine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when doxazosin is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when amoxapine is combined with isoetharine.


The risk or severity of adverse effects can be increased when propofol is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with naratriptan.


The risk or severity of adverse effects can be increased when Olopatadine is combined with aspirin.


The risk or severity of adverse effects can be increased when Mometasone is combined with edrophonium.


The risk or severity of adverse effects can be increased when captopril is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Pirlindole.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Toloxatone.


The risk or severity of adverse effects can be increased when promazine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when triflupromazine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when ATROPINE is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with naratriptan.


The risk or severity of adverse effects can be increased when reserpine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with salicylamide.


The risk or severity of adverse effects can be increased when losartan is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when losartan is combined with quinapril.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with Tramadol.


The risk or severity of adverse effects can be increased when losartan is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when acemetacin is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when losartan is combined with bumetanide.


The risk or severity of adverse effects can be increased when alprazolam is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when pentazocine is combined with protriptyline.


The risk or severity of adverse effects can be increased when prilocaine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when pentazocine is combined with flunarizine.


The risk or severity of adverse effects can be increased when pentazocine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with papaverine.


The risk or severity of adverse effects can be increased when pentazocine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with nifedipine.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with Pregabalin.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Olopatadine is combined with felbamate.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Tavaborole is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when zaleplon is combined with Remoxipride.


The risk or severity of adverse effects can be increased when brotizolam is combined with maprotiline.


The risk or severity of adverse effects can be increased when reserpine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with nimesulide.


The risk or severity of adverse effects can be increased when etodolac is combined with oxaprozin.


The risk or severity of adverse effects can be increased when zaleplon is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when fenoldopam is combined with D-mannitol.


The risk or severity of adverse effects can be increased when diclofenac is combined with DESONIDE.


The risk or severity of adverse effects can be increased when clorazepate is combined with Paliperidone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with brotizolam.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with cinoxacin.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when pentazocine is combined with furosemide.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Pramocaine is combined with desipramine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Artemether is combined with cinnarizine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Difenoxin.


The risk or severity of adverse effects can be increased when quinidine is combined with Metixene.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with furosemide.


The risk or severity of adverse effects can be increased when trimipramine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with tizanidine.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when meclizine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with paramethasone.


The risk or severity of adverse effects can be increased when halothane is combined with phenoxybenzamine.


The risk or severity of adverse effects can be increased when enflurane is combined with Ramelteon.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with resveratrol.


The risk or severity of adverse effects can be increased when suprofen is combined with aspirin.


The risk or severity of adverse effects can be increased when halothane is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when fenofibrate is combined with simvastatin.


The risk or severity of adverse effects can be increased when dyphylline is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with terazosin.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with amisulpride.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with clonidine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when Tramadol is combined with nalbuphine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with brotizolam.


The risk or severity of adverse effects can be increased when Tramadol is combined with oxazepam.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when temazepam is combined with vigabatrin.


The risk or severity of adverse effects can be increased when temazepam is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when temazepam is combined with benzocaine.


The risk or severity of adverse effects can be increased when ketorolac is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when zotepine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with carvedilol.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with pentostatin.


The risk or severity of adverse effects can be increased when thioridazine is combined with quazepam.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with nimodipine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with cilazapril.


The risk or severity of adverse effects can be increased when thioridazine is combined with prazepam.


The risk or severity of adverse effects can be increased when temazepam is combined with fludiazepam.


The risk or severity of adverse effects can be increased when brotizolam is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when benazepril is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when cetirizine is combined with protriptyline.


The risk or severity of adverse effects can be increased when antipyrine is combined with nimesulide.


The risk or severity of adverse effects can be increased when trandolapril is combined with chloroquine.


The risk or severity of adverse effects can be increased when codeine is combined with procarbazine.


The risk or severity of adverse effects can be increased when chloroquine is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when codeine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with METAXALONE.


The risk or severity of adverse effects can be increased when pergolide is combined with docetaxel.


The risk or severity of adverse effects can be increased when selegiline is combined with loxapine.


The risk or severity of adverse effects can be increased when selegiline is combined with Remoxipride.


The risk or severity of adverse effects can be increased when ethopropazine is combined with Tramadol.


The risk or severity of adverse effects can be increased when pergolide is combined with gemfibrozil.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with butalbital.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with sulpiride.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with digoxin.


The risk or severity of adverse effects can be increased when carisoprodol is combined with levodopa.


The risk or severity of adverse effects can be increased when oxazepam is combined with Remoxipride.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when oxazepam is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when fenoprofen is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when Lacidipine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when sulindac is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when Limaprost is combined with argatroban.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when midazolam is combined with Flupentixol.


The risk or severity of adverse effects can be increased when malathion is combined with Varenicline.


The risk or severity of adverse effects can be increased when maprotiline is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with tetracaine.


The risk or severity of adverse effects can be increased when butabarbital is combined with Ziprasidone.


The risk or severity of adverse effects can be increased when butabarbital is combined with butalbital.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with phenytoin.


The risk or severity of adverse effects can be increased when isoflurane is combined with zopiclone.


The risk or severity of adverse effects can be increased when maprotiline is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when DESONIDE is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when alprazolam is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when butenafine is combined with nimesulide.


The risk or severity of adverse effects can be increased when ketorolac is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when Salsalate is combined with fluocinonide.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with butamben.


The risk or severity of adverse effects can be increased when Tolcapone is combined with enalapril.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with tiapride.


The risk or severity of adverse effects can be increased when meprobamate is combined with brotizolam.


The risk or severity of adverse effects can be increased when loxapine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Icatibant.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with azelastine.


The risk or severity of adverse effects can be increased when flurazepam is combined with brotizolam.


The risk or severity of adverse effects can be increased when Agomelatine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when triazolam is combined with promethazine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when trandolapril is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when estazolam is combined with lithium ion.


The risk or severity of adverse effects can be increased when estazolam is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when estazolam is combined with Butethal.


The risk or severity of adverse effects can be increased when codeine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when estazolam is combined with amobarbital.


The risk or severity of adverse effects can be increased when triazolam is combined with Melatonin.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when doxepin is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when lidocaine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when secobarbital is combined with Asenapine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with selegiline.


The risk or severity of adverse effects can be increased when trandolapril is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when levorphanol is combined with Iloperidone.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with aspirin.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when phenmetrazine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Aclidinium is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when midazolam is combined with bupivacaine.


The risk or severity of adverse effects can be increased when midazolam is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when sulconazole is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when midazolam is combined with Etomidate.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with triprolidine.


The risk or severity of adverse effects can be increased when pentamidine is combined with Benidipine.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with triamterene.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Apremilast.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with streptozocin.


The risk or severity of adverse effects can be increased when Masoprocol is combined with carprofen.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with metolazone.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with protriptyline.


The risk or severity of adverse effects can be increased when morniflumate is combined with Masoprocol.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with cetirizine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with clomipramine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with zonisamide.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with brotizolam.


The risk or severity of adverse effects can be increased when nelfinavir is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when labetalol is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with fludiazepam.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with ethotoin.


The risk or severity of adverse effects can be increased when diazepam is combined with tizanidine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when sulpiride is combined with HEROIN.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with fenoprofen.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with tiagabine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when methysergide is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when scopolamine is combined with hyoscyamine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with promethazine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when Butoconazole is combined with nilvadipine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when buprenorphine is combined with metolazone.


The risk or severity of adverse effects can be increased when ketorolac is combined with dexamethasone.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Tolcapone is combined with clonazepam.


The risk or severity of adverse effects can be increased when Tolcapone is combined with promethazine.


The risk or severity of adverse effects can be increased when nifedipine is combined with quetiapine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with citalopram.


The risk or severity of adverse effects can be increased when triazolam is combined with olanzapine.


The risk or severity of adverse effects can be increased when brotizolam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with topiramate.


The risk or severity of adverse effects can be increased when Torasemide is combined with amikacin.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Carbetocin is combined with diltiazem.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with vigabatrin.


The risk or severity of adverse effects can be increased when levorphanol is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when levorphanol is combined with Pramocaine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with topiramate.


The risk or severity of adverse effects can be increased when pirenzepine is combined with butorphanol.


The risk or severity of adverse effects can be increased when reserpine is combined with nicardipine.


The risk or severity of adverse effects can be increased when doxazosin is combined with Aliskiren.


The risk or severity of adverse effects can be increased when alprazolam is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when reserpine is combined with efavirenz.


The risk or severity of adverse effects can be increased when efavirenz is combined with maprotiline.


The risk or severity of adverse effects can be increased when reserpine is combined with clorazepate.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with betamethasone.


The risk or severity of adverse effects can be increased when metaraminol is combined with phenmetrazine.


The risk or severity of adverse effects can be increased when zopiclone is combined with Melatonin.


The risk or severity of adverse effects can be increased when trimetrexate is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with zonisamide.


The risk or severity of adverse effects can be increased when zopiclone is combined with promethazine.


The risk or severity of adverse effects can be increased when zopiclone is combined with clonazepam.


The risk or severity of adverse effects can be increased when sertraline is combined with imipramine.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with nisoldipine.


The risk or severity of adverse effects can be increased when perphenazine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Arformoterol.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with furosemide.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with tizanidine.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with HEROIN.


The risk or severity of adverse effects can be increased when suprofen is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when Rotigotine is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when suprofen is combined with prednisone.


The risk or severity of adverse effects can be increased when buspirone is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when nabumetone is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when buprenorphine is combined with triamterene.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with terazosin.


The risk or severity of adverse effects can be increased when docetaxel is combined with Trametinib.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with triprolidine.


The risk or severity of adverse effects can be increased when amcinonide is combined with Deferasirox.


The risk or severity of adverse effects can be increased when docetaxel is combined with Afatinib.


The risk or severity of adverse effects can be increased when irbesartan is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when ketoprofen is combined with flumethasone.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with dantrolene.


The risk or severity of adverse effects can be increased when venlafaxine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when venlafaxine is combined with dihydroergotamine.


The risk or severity of adverse effects can be increased when enflurane is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when methysergide is combined with arsenic trioxide.


The risk or severity of adverse effects can be increased when selegiline is combined with formoterol.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when cocaine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with glutethimide.


The risk or severity of adverse effects can be increased when quetiapine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when rescinnamine is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when baclofen is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when nimodipine is combined with methazolamide.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with eperisone.


The risk or severity of adverse effects can be increased when Aclidinium is combined with propoxyphene.


The risk or severity of adverse effects can be increased when nimodipine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with ROLITETRACYCLINE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Retigabine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Dienogest.


The risk or severity of adverse effects can be increased when amphotericin b is combined with MOXONIDINE.


The risk or severity of adverse effects can be increased when timolol is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Tapentadol is combined with spironolactone.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with scopolamine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when loratadine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Butethal.


The risk or severity of adverse effects can be increased when salicylic acid is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when Retigabine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Olopatadine is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when niflumic acid is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when perphenazine is combined with felbamate.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Halobetasol.


The risk or severity of adverse effects can be increased when rescinnamine is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when clorazepate is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when oxazepam is combined with triazolam.


The risk or severity of adverse effects can be increased when reserpine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with salicylamide.


The risk or severity of adverse effects can be increased when oxazepam is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when oxaprozin is combined with ketoprofen.


The risk or severity of adverse effects can be increased when metoprolol is combined with Telmisartan.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with minoxidil.


The risk or severity of adverse effects can be increased when midodrine is combined with metaproterenol.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with prilocaine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with isoflurane.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with ethotoin.


The risk or severity of adverse effects can be increased when tiagabine is combined with flunarizine.


The risk or severity of adverse effects can be increased when nisoldipine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when meprobamate is combined with felbamate.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when levorphanol is combined with levodopa.


The risk or severity of adverse effects can be increased when levorphanol is combined with sevoflurane.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Nabilone.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with celecoxib.


The risk or severity of adverse effects can be increased when tetracaine is combined with maprotiline.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with Paliperidone.


The risk or severity of adverse effects can be increased when carprofen is combined with Apremilast.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with sotalol.


The risk or severity of adverse effects can be increased when lidocaine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when tolmetin is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when spironolactone is combined with labetalol.


The risk or severity of adverse effects can be increased when Naftifine is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with propranolol.


The risk or severity of adverse effects can be increased when Vildagliptin is combined with captopril.


The risk or severity of adverse effects can be increased when Rotigotine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with clonidine.


The risk or severity of adverse effects can be increased when nicergoline is combined with Isavuconazonium.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with bumetanide.


The risk or severity of adverse effects can be increased when epinephrine is combined with terbutaline.


The risk or severity of adverse effects can be increased when meprobamate is combined with oxycodone.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when tolmetin is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when Pirlindole is combined with Indacaterol.


The risk or severity of adverse effects can be increased when etizolam is combined with tiapride.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with naratriptan.


The risk or severity of adverse effects can be increased when nalbuphine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when cocaine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when enflurane is combined with primidone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with amoxapine.


The risk or severity of adverse effects can be increased when promethazine is combined with Cariprazine.


The risk or severity of adverse effects can be increased when oxazepam is combined with Etomidate.


The risk or severity of adverse effects can be increased when cocaine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when spironolactone is combined with doxazosin.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Iloperidone.


The risk or severity of adverse effects can be increased when imipramine is combined with ethotoin.


The risk or severity of adverse effects can be increased when imipramine is combined with tretinoin.


The risk or severity of adverse effects can be increased when thioridazine is combined with phenobarbital.


The risk or severity of adverse effects can be increased when Treprostinil is combined with Masoprocol.


The risk or severity of adverse effects can be increased when amphotericin b is combined with ouabain.


The risk or severity of adverse effects can be increased when meperidine is combined with propofol.


The risk or severity of adverse effects can be increased when Pinaverium is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when LISURIDE is combined with daunorubicin.


The risk or severity of adverse effects can be increased when oxymetazoline is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when thalidomide is combined with bumetanide.


The risk or severity of adverse effects can be increased when thalidomide is combined with quinapril.


The risk or severity of adverse effects can be increased when thalidomide is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when thalidomide is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with isoniazid.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with naratriptan.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with nitrazepam.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with resveratrol.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Iloperidone.


The risk or severity of adverse effects can be increased when thiopental is combined with levodopa.


The risk or severity of adverse effects can be increased when thiopental is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with prednisone.


The risk or severity of adverse effects can be increased when thiothixene is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when enalapril is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with betamethasone.


The risk or severity of adverse effects can be increased when oxaprozin is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when tolazoline is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when fluoxetine is combined with bromocriptine.


The risk or severity of adverse effects can be increased when tacrolimus is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when METAXALONE is combined with felbamate.


The risk or severity of adverse effects can be increased when Repaglinide is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when selegiline is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Olsalazine is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when buprenorphine is combined with Pirlindole.


The risk or severity of adverse effects can be increased when prednisone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when Telmisartan is combined with suprofen.


The risk or severity of adverse effects can be increased when nabumetone is combined with salicylic acid.


The risk or severity of adverse effects can be increased when dyphylline is combined with pancuronium.


The risk or severity of adverse effects can be increased when ramipril is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when hydroxyzine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Droxicam is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Phenelzine.


The risk or severity of adverse effects can be increased when selegiline is combined with bupropion.


The risk or severity of adverse effects can be increased when mesoridazine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Ximelagatran is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when haloprogin is combined with nimesulide.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when Asenapine is combined with ethotoin.


The risk or severity of adverse effects can be increased when Asenapine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Asenapine is combined with prilocaine.


The risk or severity of adverse effects can be increased when furosemide is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Olsalazine is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when cabergoline is combined with buprenorphine.


The risk or severity of adverse effects can be increased when Olsalazine is combined with Halobetasol.


The risk or severity of adverse effects can be increased when cabergoline is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with thalidomide.


The risk or severity of adverse effects can be increased when methocarbamol is combined with efavirenz.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with indapamide.


The risk or severity of adverse effects can be increased when rescinnamine is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when prazepam is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when paroxetine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Nabilone is combined with nicardipine.


The risk or severity of adverse effects can be increased when dobutamine is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with dyclonine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with propoxyphene.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when protriptyline is combined with Vilanterol.


The risk or severity of adverse effects can be increased when linezolid is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when imipramine is combined with Bretylium.


The risk or severity of adverse effects can be increased when imipramine is combined with desipramine.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with nifedipine.


The risk or severity of adverse effects can be increased when pargyline is combined with terbutaline.


The risk or severity of adverse effects can be increased when thiamylal is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when nimesulide is combined with simvastatin.


The risk or severity of adverse effects can be increased when isoflurane is combined with Fospropofol.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with loteprednol.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with scopolamine.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with reserpine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with D-mannitol.


The risk or severity of adverse effects can be increased when propofol is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with etodolac.


The risk or severity of adverse effects can be increased when nitric oxide is combined with mafenide.


The risk or severity of adverse effects can be increased when nitrendipine is combined with nicardipine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Agomelatine.


The risk or severity of adverse effects can be increased when loratadine is combined with meclizine.


The risk or severity of adverse effects can be increased when halothane is combined with Nebivolol.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with diflunisal.


The risk or severity of adverse effects can be increased when proparacaine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with nitric oxide.


The risk or severity of adverse effects can be increased when clorazepate is combined with butalbital.


The risk or severity of adverse effects can be increased when Olmesartan is combined with furosemide.


The risk or severity of adverse effects can be increased when loxapine is combined with Retigabine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with tizanidine.


The risk or severity of adverse effects can be increased when docetaxel is combined with atorvastatin.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when docetaxel is combined with Fludarabine.


The risk or severity of adverse effects can be increased when suprofen is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when Propacetamol is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Olopatadine.


The risk or severity of adverse effects can be increased when prazepam is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Mometasone.


The risk or severity of adverse effects can be increased when Asenapine is combined with benzocaine.


The risk or severity of adverse effects can be increased when rapamycin is combined with nisoldipine.


The risk or severity of adverse effects can be increased when Asenapine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with atenolol.


The risk or severity of adverse effects can be increased when tiapride is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when Pentyl nitrite is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when tolmetin is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when salicylic acid is combined with flunarizine.


The risk or severity of adverse effects can be increased when meclizine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Pinaverium.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with vigabatrin.


The risk or severity of adverse effects can be increased when oxymorphone is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when irbesartan is combined with trandolapril.


The risk or severity of adverse effects can be increased when Olsalazine is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when apraclonidine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when meprobamate is combined with Melatonin.


The risk or severity of adverse effects can be increased when Naftifine is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when pramipexole is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Masoprocol is combined with flumethasone.


The risk or severity of adverse effects can be increased when butorphanol is combined with Perospirone.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Mersalyl.


The risk or severity of adverse effects can be increased when trandolapril is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when fosinopril is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when methysergide is combined with mefloquine.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when methysergide is combined with methylergonovine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when aspirin is combined with ketoprofen.


The risk or severity of adverse effects can be increased when enalapril is combined with papaverine.


The risk or severity of adverse effects can be increased when trichlormethiazide is combined with ouabain.


The risk or severity of adverse effects can be increased when promazine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with moclobemide.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with ambenonium.


The risk or severity of adverse effects can be increased when butorphanol is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when Pentolinium is combined with butorphanol.


The risk or severity of adverse effects can be increased when flurazepam is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when nimesulide is combined with alclofenac.


The risk or severity of adverse effects can be increased when carprofen is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when diltiazem is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Quinine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with clorazepate.


The risk or severity of adverse effects can be increased when nabumetone is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when meperidine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Lurasidone is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when estrone is combined with Echothiophate.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Sorafenib.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when oxazepam is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when reserpine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when clozapine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when Bevantolol is combined with pilocarpine.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with Pentolinium.


The risk or severity of adverse effects can be increased when diflorasone is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when procaine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when Sacubitril is combined with epirizole.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Olopatadine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with Difenoxin.


The risk or severity of adverse effects can be increased when pergolide is combined with zafirlukast.


The risk or severity of adverse effects can be increased when indomethacin is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when indomethacin is combined with formestane.


The risk or severity of adverse effects can be increased when moclobemide is combined with dobutamine.


The risk or severity of adverse effects can be increased when olanzapine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when itraconazole is combined with Clevidipine.


The risk or severity of adverse effects can be increased when olanzapine is combined with zaleplon.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Agomelatine.


The risk or severity of adverse effects can be increased when olanzapine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Lurasidone.


The risk or severity of adverse effects can be increased when protriptyline is combined with flunarizine.


The risk or severity of adverse effects can be increased when Miltefosine is combined with nitrendipine.


The risk or severity of adverse effects can be increased when protriptyline is combined with celiprolol.


The risk or severity of adverse effects can be increased when Voriconazole is combined with eperisone.


The risk or severity of adverse effects can be increased when HEROIN is combined with felbamate.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when clonidine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Metixene is combined with levorphanol.


The risk or severity of adverse effects can be increased when griseofulvin is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with promethazine.


The risk or severity of adverse effects can be increased when levorphanol is combined with efavirenz.


The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when haloprogin is combined with Efonidipine.


The risk or severity of adverse effects can be increased when prilocaine is combined with efavirenz.


The risk or severity of adverse effects can be increased when methysergide is combined with danazol.


The risk or severity of adverse effects can be increased when Halazepam is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Eletriptan is combined with meperidine.


The risk or severity of adverse effects can be increased when Spirapril is combined with oxaprozin.


The risk or severity of adverse effects can be increased when ketamine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when fludiazepam is combined with clonidine.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with zotepine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with imipramine.


The risk or severity of adverse effects can be increased when nicardipine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when losartan is combined with sulindac.


The risk or severity of adverse effects can be increased when ethosuximide is combined with ethotoin.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with budesonide.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when carisoprodol is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Talniflumate is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Talniflumate is combined with suprofen.


The risk or severity of adverse effects can be increased when Halobetasol is combined with Deferasirox.


The risk or severity of adverse effects can be increased when isoxsuprine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when chloroquine is combined with formestane.


The risk or severity of adverse effects can be increased when chloroquine is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when ketamine is combined with memantine.


The risk or severity of adverse effects can be increased when flurazepam is combined with tizanidine.


The risk or severity of adverse effects can be increased when thalidomide is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Epirubicin.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when tiapride is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Milnacipran.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Pramocaine.


The risk or severity of adverse effects can be increased when tiapride is combined with Ramelteon.


The risk or severity of adverse effects can be increased when prilocaine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with betamethasone.


The risk or severity of adverse effects can be increased when phenobarbital is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when fluoxetine is combined with sumatriptan.


The risk or severity of adverse effects can be increased when carbamazepine is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when meprobamate is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when fenbufen is combined with estrone.


The risk or severity of adverse effects can be increased when haloperidol is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Melatonin.


The risk or severity of adverse effects can be increased when isoflurane is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when bromocriptine is combined with cilostazol.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with promethazine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with terazosin.


The risk or severity of adverse effects can be increased when triazolam is combined with Paliperidone.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when tolazoline is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when dicyclomine is combined with pirenzepine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when ticlopidine is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with flunarizine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with brotizolam.


The risk or severity of adverse effects can be increased when triamterene is combined with nicardipine.


The risk or severity of adverse effects can be increased when ramipril is combined with terazosin.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when halothane is combined with Pipamperone.


The risk or severity of adverse effects can be increased when cilazapril is combined with tolmetin.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when oxycodone is combined with Ramelteon.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when ATROPINE is combined with nalbuphine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Pizotifen.


The risk or severity of adverse effects can be increased when gliclazide is combined with ethanol.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when isoflurane is combined with oxymorphone.


The risk or severity of adverse effects can be increased when isoflurane is combined with captopril.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with zotepine.


The risk or severity of adverse effects can be increased when prilocaine is combined with prazepam.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with nilvadipine.


The risk or severity of adverse effects can be increased when metolazone is combined with penbutolol.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when codeine is combined with amoxapine.


The risk or severity of adverse effects can be increased when trandolapril is combined with felodipine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when loxapine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when nimodipine is combined with losartan.


The risk or severity of adverse effects can be increased when ropinirole is combined with fosinopril.


The risk or severity of adverse effects can be increased when benztropine is combined with Vecuronium.


The risk or severity of adverse effects can be increased when benztropine is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when Eletriptan is combined with zotepine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with MELPERONE.


The risk or severity of adverse effects can be increased when benztropine is combined with pancuronium.


The risk or severity of adverse effects can be increased when lidocaine is combined with zotepine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with apraclonidine.


The risk or severity of adverse effects can be increased when etizolam is combined with butalbital.


The risk or severity of adverse effects can be increased when chloroquine is combined with carprofen.


The risk or severity of adverse effects can be increased when promazine is combined with Normethadone.


The risk or severity of adverse effects can be increased when HEROIN is combined with butamben.


The risk or severity of adverse effects can be increased when formestane is combined with edrophonium.


The risk or severity of adverse effects can be increased when Sacubitril is combined with methyldopa.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with benazepril.


The risk or severity of adverse effects can be increased when leflunomide is combined with haloperidol.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Halobetasol.


The risk or severity of adverse effects can be increased when quazepam is combined with amisulpride.


The risk or severity of adverse effects can be increased when Etomidate is combined with primidone.


The risk or severity of adverse effects can be increased when nortriptyline is combined with flunarizine.


The risk or severity of adverse effects can be increased when cocaine is combined with cetirizine.


The risk or severity of adverse effects can be increased when procaine is combined with phenytoin.


The risk or severity of adverse effects can be increased when ramipril is combined with cilazapril.


The risk or severity of adverse effects can be increased when hydromorphone is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Eplerenone.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with methazolamide.


The risk or severity of adverse effects can be increased when METAXALONE is combined with scopolamine.


The risk or severity of adverse effects can be increased when benazepril is combined with captopril.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with mitoxantrone.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with loratadine.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with amcinonide.


The risk or severity of adverse effects can be increased when butenafine is combined with gabapentin.


The risk or severity of adverse effects can be increased when diclofenac is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with imipramine.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when lidocaine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when clomipramine is combined with methazolamide.


The risk or severity of adverse effects can be increased when benazepril is combined with acebutolol.


The risk or severity of adverse effects can be increased when triprolidine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when clomipramine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when butenafine is combined with felodipine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Olopatadine.


The risk or severity of adverse effects can be increased when metolazone is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when Treprostinil is combined with alclofenac.


The risk or severity of adverse effects can be increased when apomorphine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when lithium ion is combined with clemastine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with butalbital.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when valsartan is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Netupitant.


The risk or severity of adverse effects can be increased when bepridil is combined with pramipexole.


The risk or severity of adverse effects can be increased when fenoprofen is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when doxepin is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when brotizolam is combined with citalopram.


The risk or severity of adverse effects can be increased when diflunisal is combined with salicylamide.


The risk or severity of adverse effects can be increased when fosinopril is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when tiapride is combined with flunarizine.


The risk or severity of adverse effects can be increased when Efonidipine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with tubocurarine.


The risk or severity of adverse effects can be increased when butabarbital is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when Butethal is combined with Pizotifen.


The risk or severity of adverse effects can be increased when ketorolac is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when temazepam is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when risperidone is combined with etizolam.


The risk or severity of adverse effects can be increased when betaxolol is combined with fosinopril.


The risk or severity of adverse effects can be increased when amiodarone is combined with benazepril.


The risk or severity of adverse effects can be increased when Clevidipine is combined with fluvastatin.


The risk or severity of adverse effects can be increased when maprotiline is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when Halazepam is combined with dantrolene.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with promazine.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when amobarbital is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Caspofungin is combined with bepridil.


The risk or severity of adverse effects can be increased when amobarbital is combined with quazepam.


The risk or severity of adverse effects can be increased when amobarbital is combined with prazepam.


The risk or severity of adverse effects can be increased when quetiapine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when pimozide is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when pimozide is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when quetiapine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when quetiapine is combined with prazepam.


The risk or severity of adverse effects can be increased when quetiapine is combined with quazepam.


The risk or severity of adverse effects can be increased when sumatriptan is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with zopiclone.


The risk or severity of adverse effects can be increased when propofol is combined with benzocaine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with selegiline.


The risk or severity of adverse effects can be increased when betaxolol is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when propofol is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when propofol is combined with vigabatrin.


The risk or severity of adverse effects can be increased when estazolam is combined with Asenapine.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when protriptyline is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when equilin is combined with metoclopramide.


The risk or severity of adverse effects can be increased when quetiapine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when sertraline is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when quetiapine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when scopolamine is combined with desipramine.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with prednisone.


The risk or severity of adverse effects can be increased when betaxolol is combined with lisinopril.


The risk or severity of adverse effects can be increased when dibucaine is combined with tetracaine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when antipyrine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when antipyrine is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when estazolam is combined with cocaine.


The risk or severity of adverse effects can be increased when estazolam is combined with tiagabine.


The risk or severity of adverse effects can be increased when estazolam is combined with zonisamide.


The risk or severity of adverse effects can be increased when glutethimide is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Rufinamide is combined with ethotoin.


The risk or severity of adverse effects can be increased when Rufinamide is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with isoflurane.


The risk or severity of adverse effects can be increased when Rufinamide is combined with prilocaine.


The risk or severity of adverse effects can be increased when diclofenac is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Asenapine.


The risk or severity of adverse effects can be increased when diclofenac is combined with paramethasone.


The risk or severity of adverse effects can be increased when dibucaine is combined with amoxapine.


The risk or severity of adverse effects can be increased when dibucaine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Phenelzine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with budesonide.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with tiapride.


The risk or severity of adverse effects can be increased when propranolol is combined with Eprosartan.


The risk or severity of adverse effects can be increased when sevoflurane is combined with trandolapril.


The risk or severity of adverse effects can be increased when Lacidipine is combined with tretinoin.


The risk or severity of adverse effects can be increased when Mometasone is combined with tubocurarine.


The risk or severity of adverse effects can be increased when celecoxib is combined with desoximetasone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when bupivacaine is combined with spironolactone.


The risk or severity of adverse effects can be increased when furosemide is combined with cilazapril.


The risk or severity of adverse effects can be increased when Nepafenac is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with cilazapril.


The risk or severity of adverse effects can be increased when enflurane is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Tixocortol.


The risk or severity of adverse effects can be increased when protriptyline is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with equilin.


The risk or severity of adverse effects can be increased when procyclidine is combined with ATROPINE.


The risk or severity of adverse effects can be increased when dyclonine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when sotalol is combined with Cevimeline.


The risk or severity of adverse effects can be increased when sotalol is combined with nicotine.


The risk or severity of adverse effects can be increased when amoxapine is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with clidinium.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Bambuterol.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Butethal.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when meperidine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when amitriptyline is combined with clenbuterol.


The risk or severity of adverse effects can be increased when morniflumate is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when labetalol is combined with bumetanide.


The risk or severity of adverse effects can be increased when indomethacin is combined with prednisone.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with protriptyline.


The risk or severity of adverse effects can be increased when clorazepate is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with azelastine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with cetirizine.


The risk or severity of adverse effects can be increased when dantrolene is combined with Pizotifen.


The risk or severity of adverse effects can be increased when procaine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with nifedipine.


The risk or severity of adverse effects can be increased when Agomelatine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with fludiazepam.


The risk or severity of adverse effects can be increased when haloprogin is combined with isradipine.


The risk or severity of adverse effects can be increased when codeine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when codeine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when isoproterenol is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when cilazapril is combined with Sacubitril.


The risk or severity of adverse effects can be increased when codeine is combined with benzocaine.


The risk or severity of adverse effects can be increased when estazolam is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when flurazepam is combined with thiamylal.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Vismodegib.


The risk or severity of adverse effects can be increased when benazepril is combined with etodolac.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with rivastigmine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with etodolac.


The risk or severity of adverse effects can be increased when pentazocine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when benazepril is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Rufinamide is combined with benzocaine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when Rufinamide is combined with vigabatrin.


The risk or severity of adverse effects can be increased when risperidone is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when benazepril is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when difluprednate is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when butabarbital is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when ondansetron is combined with clonidine.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with fleroxacin.


The risk or severity of adverse effects can be increased when celecoxib is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when butamben is combined with dantrolene.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with bumetanide.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when fluconazole is combined with oxycodone.


The risk or severity of adverse effects can be increased when scopolamine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when propofol is combined with Normethadone.


The risk or severity of adverse effects can be increased when thiopental is combined with zotepine.


The risk or severity of adverse effects can be increased when thiopental is combined with MELPERONE.


The risk or severity of adverse effects can be increased when oxycodone is combined with Alvimopan.


The risk or severity of adverse effects can be increased when alclofenac is combined with equilin.


The risk or severity of adverse effects can be increased when Etomidate is combined with Etidocaine.


The risk or severity of adverse effects can be increased when triazolam is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Bortezomib is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Torasemide is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when sulpiride is combined with efavirenz.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Sodium oxybate is combined with nefazodone.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Mometasone.


The risk or severity of adverse effects can be increased when benzoic acid is combined with nitrendipine.


The risk or severity of adverse effects can be increased when temazepam is combined with buspirone.


The risk or severity of adverse effects can be increased when clorazepate is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when antipyrine is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when estazolam is combined with ondansetron.


The risk or severity of adverse effects can be increased when tretinoin is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when propofol is combined with dibucaine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with ethotoin.


The risk or severity of adverse effects can be increased when tretinoin is combined with doxazosin.


The risk or severity of adverse effects can be increased when amitriptyline is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with pancuronium.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Eprosartan is combined with celecoxib.


The risk or severity of adverse effects can be increased when scopolamine is combined with Pentolinium.


The risk or severity of adverse effects can be increased when tretinoin is combined with labetalol.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with resveratrol.


The risk or severity of adverse effects can be increased when metoprolol is combined with apraclonidine.


The risk or severity of adverse effects can be increased when butabarbital is combined with Pizotifen.


The risk or severity of adverse effects can be increased when timolol is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Nepafenac is combined with betamethasone.


The risk or severity of adverse effects can be increased when quazepam is combined with triflupromazine.


The risk or severity of adverse effects can be increased when chlortetracycline is combined with tretinoin.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with methocarbamol.


The risk or severity of adverse effects can be increased when alclometasone is combined with Demecarium.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with spironolactone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with triprolidine.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when Escitalopram is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Escitalopram is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when methylergonovine is combined with dimethyl sulfoxide.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when isradipine is combined with metolazone.


The risk or severity of adverse effects can be increased when benzocaine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when pergolide is combined with arsenic trioxide.


The risk or severity of adverse effects can be increased when pergolide is combined with cilostazol.


The risk or severity of adverse effects can be increased when nitrazepam is combined with topiramate.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when Limaprost is combined with Bivalirudin.


The risk or severity of adverse effects can be increased when benzocaine is combined with amisulpride.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with flumethasone.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with dibucaine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with metolazone.


The risk or severity of adverse effects can be increased when pimozide is combined with Olopatadine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Remoxipride.


The risk or severity of adverse effects can be increased when nystatin is combined with nitrendipine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when Droxicam is combined with fluocinonide.


The risk or severity of adverse effects can be increased when aspirin is combined with Droxicam.


The risk or severity of adverse effects can be increased when amphotericin b is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with Arformoterol.


The risk or severity of adverse effects can be increased when morniflumate is combined with acemetacin.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with clonidine.


The risk or severity of adverse effects can be increased when gabapentin is combined with imipramine.


The risk or severity of adverse effects can be increased when alprazolam is combined with Perospirone.


The risk or severity of adverse effects can be increased when Eribulin is combined with clozapine.


The risk or severity of adverse effects can be increased when gabapentin is combined with loratadine.


The risk or severity of adverse effects can be increased when metronidazole is combined with disulfiram.


The risk or severity of adverse effects can be increased when amobarbital is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Perospirone is combined with Ramelteon.


The risk or severity of adverse effects can be increased when halothane is combined with amisulpride.


The risk or severity of adverse effects can be increased when Perospirone is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when phentolamine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when butamben is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Butethal.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with amobarbital.


The risk or severity of adverse effects can be increased when tretinoin is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with lithium ion.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when pargyline is combined with apraclonidine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with penbutolol.


The risk or severity of adverse effects can be increased when bumetanide is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when ethosuximide is combined with Difenoxin.


The risk or severity of adverse effects can be increased when midazolam is combined with efavirenz.


The risk or severity of adverse effects can be increased when halcinonide is combined with ambenonium.


The risk or severity of adverse effects can be increased when phenylpropanolamine is combined with benzphetamine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with lisinopril.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Articaine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with etizolam.


The risk or severity of adverse effects can be increased when cabergoline is combined with felodipine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with carisoprodol.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with clonazepam.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with promethazine.


The risk or severity of adverse effects can be increased when Propiverine is combined with pentazocine.